Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"
Circulation: Genomic and Precision Medicine
Saved in:
Main Authors: | Aw JWX, Tan DSY, Goh LL |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176990 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Response to letter regarding article, "prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention"
by: Fearon, W.F., et al.
Published: (2016) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2011) -
Optimal antiplatelet treatment for percutaneous coronary intervention: Clopidogrel vs. ticlopidine
by: Almsherqi, Z.A., et al.
Published: (2016) -
Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in Singapore
by: Kim, Ji Heon, et al.
Published: (2021) -
Expert consensus on Dual Antiplatelet Therapy (DAPT) for acute coronary syndrome in Thailand: Review article
by: R. Kunjara-Na-Ayudhya, et al.
Published: (2020)